Welcome back to Action Potential, join us this week as we welcome Dr. Deborah Clegg, VP of Research at Texas Tech University.

What you'll get from this episode:

• Dr. Deborah Clegg's journey from dietitian to VP of research at Texas Tech University.
• The vital role of nutrition in managing cardio-renal metabolic diseases.
• Importance of real-time data for empowering patients with kidney disease.
• Challenges and potential of biosensors for continuous potassium monitoring.
• Advocacy for re-evaluating dietary guidelines for kidney disease patients.

Thank you to our sponsor ProtonIntel: “At ProtonIntel, we are building the first real-time, continuous potassium monitoring wearable, allowing clinicians to treat and manage kidney disease patients more safely and precisely. Life-saving treatments that cannot be deployed when patients have dangerous K+ levels today will be unlocked for safe and optimal use."

Follow Action Potential: https://www.linkedin.com/company/action-potential-podcast/about/

This show is part of the Slice of Healthcare podcast network: https://www.linkedin.com/company/sliceofhealthcare/

Welcome back to Action Potential, join us this week as we welcome Lilian Okonkwo, Senior Director of Hospital Services at Strive Health.

What you'll get from this episode:

• Patient Vulnerability and Education: Lilian Okonkwo emphasizes the crucial role of patient education in acute care settings, particularly for those with chronic kidney disease (CKD) and end-stage kidney disease (ESKD). The moment of hospitalization often marks a point of vulnerability and openness to learning about their condition and treatment options.
• Transition to Value-Based Care Programs: The transition from hospital to value-based care programs is highlighted as a vital step in managing kidney disease. These programs focus on continuous education and care coordination, which are key to reducing hospital readmissions and improving patient outcomes.
• Dietary Guidance and Medication Management: A significant part of managing kidney disease involves educating patients about diet and medication. Value-based care provides resources like dietitians and medication management to help patients slow disease progression and manage their condition effectively.
• Importance of Remote Monitoring: Lilian Okonkwo discusses the potential of remote monitoring in kidney care, especially for tracking vital parameters like creatinine and potassium levels. This technology could enable better disease management and prevent hospital readmissions.
• Future Aspirations in Kidney Care: The conversation concludes with a hopeful outlook on future advancements in kidney care, including new technologies and approaches to managing the disease more effectively and improving patient quality of life.

Thank you to our sponsor ProtonIntel: “At ProtonIntel, we are building the first real-time, continuous potassium monitoring wearable, allowing clinicians to treat and manage kidney disease patients more safely and precisely. Life-saving treatments that cannot be deployed when patients have dangerous K+ levels today will be unlocked for safe and optimal use."

Learn more about Lilian Okonkwo: https://www.linkedin.com/in/lilian-okonkwo-msn-rn-agnp-bc-b646064a/

Follow Action Potential: https://www.linkedin.com/company/action-potential-podcast/about/

This show is part of the Slice of Healthcare podcast network: https://www.linkedin.com/company/sliceofhealthcare/

Welcome back to Action Potential, join us this week as we welcome Bill Van Antwerp, Founder and CSO at Laxmi, a leading expert in diabetes care.

What you'll get from this episode:

• Trailblazing in Remote Physiological Monitoring: Bill Van Antwerp shares his extensive experience in developing insulin pumps and the first FDA-approved CGM (Continuous Glucose Monitor), paving the way for modern diabetes care.
• Innovative Solutions Overcoming Manufacturing Challenges: Van Antwerp discusses the complex journey from concept to mass production, highlighting the difficulty in manufacturing reliable, consistent sensors at scale.
• The Evolution of CGM Technology: He reflects on the evolution of CGM, from initial skepticism and regulatory hurdles to its current status as a standard care tool for managing diabetes.
• Patient Empowerment through Technology: Van Antwerp emphasizes how CGMs have empowered patients, particularly in making informed decisions based on real-time data, a significant shift from the earlier FDA restrictions.
• Future Directions in Sensor Technology: Looking ahead, Van Antwerp discusses the potential of non-invasive methods and the importance of directly measuring targeted analytes for accurate and clinically actionable data.

Thank you to our sponsor ProtonIntel: “At ProtonIntel, we are building the first real-time, continuous potassium monitoring wearable, allowing clinicians to treat and manage kidney disease patients more safely and precisely. Life-saving treatments that cannot be deployed when patients have dangerous K+ levels today will be unlocked for safe and optimal use."

Learn more about Bill Van Antwerp: https://www.linkedin.com/in/bill-van-antwerp-35848052/

Follow Action Potential: https://www.linkedin.com/company/action-potential-podcast/about/

This show is part of the Slice of Healthcare podcast network: https://www.linkedin.com/company/sliceofhealthcare/